Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Orthocell Ltd ( (AU:OCC) ) just unveiled an announcement.
Orthocell Ltd announced the cessation of 250,000 securities due to the expiry of options or other convertible securities that were not exercised or converted by July 13, 2025. This cessation of securities may impact the company’s capital structure but is a routine part of managing financial instruments and does not indicate any immediate operational or strategic shifts.
The most recent analyst rating on (AU:OCC) stock is a Buy with a A$1.32 price target. To see the full list of analyst forecasts on Orthocell Ltd stock, see the AU:OCC Stock Forecast page.
More about Orthocell Ltd
Orthocell Ltd operates in the biotechnology industry, focusing on regenerative medicine and tissue engineering. The company specializes in developing and commercializing products for the repair and regeneration of soft tissue injuries.
Average Trading Volume: 1,075,043
Technical Sentiment Signal: Buy
Current Market Cap: A$309.7M
Learn more about OCC stock on TipRanks’ Stock Analysis page.